Federal award
DMS PHARMACEUTICAL GROUP INC
SPE2DP26F3734
Contract
Obligated and Ceiling
- Obligated (net)
- $12,337.92
- Ceiling (potential value, not spending)
- $12,337.92
- Current value
- $12,337.92
- Gross positive obligations
- $34,675.20
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- DMS PHARMACEUTICAL GROUP INC · PX72BSBQTKJ3
- Owner company
- DMS Pharmaceutical GroupBasis direct: the recipient is the company's own reviewed UEI.
- Reported parent
- DMS PHARMACEUTICAL GROUP INC · PX72BSBQTKJ3
- Awarding agency
- Department of Defense · sub-agency 97AS · office SPE2DP
- Funding agency
- Department of Defense · sub-agency 97AS
- Product or service (PSC)
- 6505 · DRUGS AND BIOLOGICALS
- Industry (NAICS)
- 424210 · DRUGS AND DRUGGISTS' SUNDRIES MERCHANT WHOLESALERS
- PIID
- SPE2DP26F3734
- Parent vehicle (IDV PIID)
- SPE2DX25D9900
- Award type code
- C
- Actions
- 2 · Mar 24, 2026 to Mar 25, 2026
- Why it is listed
- reviewed company, $10k or more
Action History2
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Mar 25, 2026 | FY2026 | P00001 | D | −$22,337.28 | |
| Mar 24, 2026 | FY2026 | 0 | — | $34,675.20 |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.